RxDoctor Payments DataLook up a doctor →

Priyavadan Shah

Cardiovascular Disease · Cary, NCNPI 1679561369

Payments from drug & device makers

$870,964in general payments, 2019–2025

Across 748 payments — averaging $1164.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kowa Research Institute, Inc.$577K
  • Esperion Therapeutics, Inc.$236K
  • Novartis$53K
  • Johnson & Johnson$1K
  • AstraZeneca$759
  • Amgen$611
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$5,677100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$870,964 in reported general payments places this provider in the 95th percentile of 727 cardiovascular disease providers in North Carolina.

See all cardiovascular disease providers in North Carolina

Other cardiovascular disease in Cary

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →